Literature DB >> 31608717

Reproductive immunomodulatory functions of B cells in pregnancy.

Sulagna Dutta1, Pallav Sengupta2, Nazmul Haque1.   

Abstract

Pregnancy, a challenging physiological state, requires shuffling of conventional immune work-sets. Strategies to tolerate the semi-allogenic fetus in normal human pregnancy are multivariate with perfect modulation of the immune cells. Pregnancy is marked by B cell lymphocytopenia accompanied by reduced responsiveness to infectious agents. Besides this old age concept, plenty of research confirms that B cells have other crucial roles in pregnancy and undergo a wide range of modifications in terms of its proliferation, switching between its subtypes, variation in antibody productions, shifting the tides of cytokines as well as regulating other immune cells. B cells establish tolerant environment in pregnancy by producing protective antibodies to encounter the foreign paternal antigens. Regulatory B cells (Bregs) have adopted anti-inflammatory characteristics to sustain normal pregnancy. Moreover, the colossal physiological alterations during human pregnancy also include synchronized changes in the cross-talks between the pregnancy hormones and B cells. These aspects of pregnancy from the view point of B cell functions have so far appeared individually in discrete reports. This review finds its novelty in concisely presenting every facet of association of B cell with human pregnancy.

Entities:  

Keywords:  Asymmetric antibodies; B cell; IL-10; hormones; pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31608717     DOI: 10.1080/08830185.2019.1674299

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  8 in total

Review 1.  The molecular tug of war between immunity and fertility: Emergence of conserved signaling pathways and regulatory mechanisms.

Authors:  Nikki Naim; Francis R G Amrit; T Brooke McClendon; Judith L Yanowitz; Arjumand Ghazi
Journal:  Bioessays       Date:  2020-11-09       Impact factor: 4.345

2.  A Comprehensive Investigation into the Distribution of Circulating B Cell Subsets in the Third Trimester of Pregnancy.

Authors:  Ágnes Kövér; Rudolf Lampé; Krisztina Szabó; Tünde Tarr; Gábor Papp
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

3.  Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance.

Authors:  Jerry Guintivano; Karolina A Aberg; Shaunna L Clark; David R Rubinow; Patrick F Sullivan; Samantha Meltzer-Brody; Edwin J C G van den Oord
Journal:  Mol Psychiatry       Date:  2022-04-01       Impact factor: 13.437

Review 4.  The Role of B Cells in PE Pathophysiology: A Potential Target for Perinatal Cell-Based Therapy?

Authors:  Marta Magatti; Alice Masserdotti; Anna Cargnoni; Andrea Papait; Francesca Romana Stefani; Antonietta Rosa Silini; Ornella Parolini
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

Review 5.  Gestational Diabetes Mellitus and Maternal Immune Dysregulation: What We Know So Far.

Authors:  Colm J McElwain; Fergus P McCarthy; Cathal M McCarthy
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

6.  IL-10 Producing B Cells Protect against LPS-Induced Murine Preterm Birth by Promoting PD1- and ICOS-Expressing T Cells.

Authors:  Mandy Busse; Ana Claudia Zenclussen
Journal:  Cells       Date:  2022-08-29       Impact factor: 7.666

7.  Continuous activation of polymorphonuclear myeloid-derived suppressor cells during pregnancy is critical for fetal development.

Authors:  Mengyu Shi; Ziyang Chen; Meiqi Chen; Jingping Liu; Jing Li; Zhe Xing; Xiaogang Zhang; Shuaijun Lv; Xinyao Li; Shaowen Zuo; Shi Feng; Ying Lin; Gang Xiao; Liping Wang; Yumei He
Journal:  Cell Mol Immunol       Date:  2021-06-07       Impact factor: 22.096

8.  Supraphysiological estradiol promotes human T follicular helper cell differentiation and favours humoural immunity during in vitro fertilization.

Authors:  Cong Hu; HongLei Liu; Bo Pang; Hao Wu; Xiuying Lin; Yu Zhen; Huanfa Yi
Journal:  J Cell Mol Med       Date:  2021-05-24       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.